Title:
PYRIMIDINE DERIVATIVE AS WEE1 INHIBITOR
Document Type and Number:
WIPO Patent Application WO/2021/043152
Kind Code:
A1
Abstract:
The present invention relates to a novel compound represented by formula (1A) or formula (1B) and/or a pharmaceutically acceptable salt thereof, a composition containing the compound represented by formula (1A) or formula (1B) and/or a pharmaceutically acceptable salt thereof, a preparation method for said compound, and use of said compound as a Wee1 inhibitor in the preparation of anti-tumor drugs.
Inventors:
XIE YULI (CN)
FAN HOUXING (CN)
FAN HOUXING (CN)
Application Number:
PCT/CN2020/112948
Publication Date:
March 11, 2021
Filing Date:
September 02, 2020
Export Citation:
Assignee:
WIGEN BIOMEDICINE TECH SHANGHAI CO LTD (CN)
International Classes:
C07D487/14; A61K31/519; A61P35/00; C07D471/14; C07D487/04
Domestic Patent References:
WO2019028008A1 | 2019-02-07 | |||
WO2018108084A1 | 2018-06-21 |
Foreign References:
CN101784551A | 2010-07-21 | |||
CN101784551A | 2010-07-21 | |||
CN103703005A | 2014-04-02 | |||
CN109020981A | 2018-12-18 | |||
CN109422754A | 2019-03-05 | |||
CN109810111A | 2019-05-28 | |||
CN108699055A | 2018-10-23 |
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: